Using its deep virology expertise and targeted genome editing technologies, including CRISPR/Cas9, Agenovir’s mission is to develop innovative treatments that disrupt or eliminate pathogenic viral genomes, bringing hope to patients who suffer from devastating, persistent viral infection. To learn more about Agenovir and opportunities for partnership, complete the form below or contact us.

Fill out my online form.
Contact Us

7000 Shoreline Court, Suite 320
South San Francisco, CA 94080

Telephone: (650) 287-3300